Related references
Note: Only part of the references are listed.Multidose Priming and Delayed Boosting Improve Plasmodium falciparum Sporozoite Vaccine Efficacy Against Heterologous P. falciparum Controlled Human Malaria Infection
Kirsten E. Lyke et al.
CLINICAL INFECTIOUS DISEASES (2021)
γδ T cells suppress Plasmodium falciparum blood-stage infection by direct killing and phagocytosis
Caroline Junqueira et al.
NATURE IMMUNOLOGY (2021)
Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunity
Agnes Mwakingwe-Omari et al.
NATURE (2021)
Safety, immunogenicity and efficacy of PfSPZ Vaccine against malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2 trial
Martina Oneko et al.
NATURE MEDICINE (2021)
Glycolipid-peptide vaccination induces liver-resident memory CD8+ T cells that protect against rodent malaria
Lauren E. Holz et al.
SCIENCE IMMUNOLOGY (2020)
Safety and Differential Antibody and T-Cell Responses to the Plasmodium falciparum Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and Infants
Said A. Jongo et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2019)
Impact of Sickle Cell Trait and Naturally Acquired Immunity on Uncomplicated Malaria after Controlled Human Malaria Infection in Adults in Gabon
Bertrand Lell et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2018)
γδ T Cells Are Required for the Induction of Sterile Immunity during Irradiated Sporozoite Vaccinations
Irfan Zaidi et al.
JOURNAL OF IMMUNOLOGY (2017)
Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial
Mahamadou S. Sissoko et al.
LANCET INFECTIOUS DISEASES (2017)
Sterile protection against human malaria by chemoattenuated PfSPZ vaccine
Benjamin Mordmueller et al.
NATURE (2017)
Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection
Kirsten E. Lyke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Protection against Plasmodium falciparum malaria by PfSPZ Vaccine
Judith E. Epstein et al.
JCI INSIGHT (2017)
Protection against malaria at 1 year and immune correlates following PfSPZ vaccination
Andrew S. Ishizuka et al.
NATURE MEDICINE (2016)
Multi-parallel qPCR provides increased sensitivity and diagnostic breadth for gastrointestinal parasites of humans: field-based inferences on the impact of mass deworming
Alice V. Easton et al.
PARASITES & VECTORS (2016)
Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial
H. Tinto et al.
LANCET (2015)
Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres
Benjamin Mordmueller et al.
MALARIA JOURNAL (2015)
Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines
Thomas L. Richie et al.
VACCINE (2015)
Controlled Human Malaria Infection of Tanzanians by Intradermal Injection of Aseptic, Purified, Cryopreserved Plasmodium falciparum Sporozoites
Seif Shekalaghe et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2014)
Controlled Human Malaria Infections by Intradermal Injection of Cryopreserved Plasmodium falciparum Sporozoites
Meta Roestenbeng et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2013)
Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine
Robert A. Seder et al.
SCIENCE (2013)
Control of Plasmodium falciparum erythrocytic cycle: γδ T cells target the red blood cell-invasive merozoites
Giulia Costa et al.
BLOOD (2011)
Live Attenuated Malaria Vaccine Designed to Protect Through Hepatic CD8+ T Cell Immunity
J. E. Epstein et al.
SCIENCE (2011)
Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria
Stephen L. Hoffman et al.
HUMAN VACCINES (2010)
Evaluation of RTS,S/AS02A and RTS,S/AS01B in Adults in a High Malaria Transmission Area
Mark E. Polhemus et al.
PLOS ONE (2009)
Year-to-year variation in the age-specific incidence of clinical malaria in two potential vaccine testing sites in Mali with different levels of malaria transmission intensity
Alassane Dicko et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2007)
Efficacy of RTS,S/ASO2 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia:: a randomised trial
KA Bojang et al.
LANCET (2001)
Share Paper
